News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kirin Brewery Co., Ltd. (KNBWY) Introduces Pneumococcal Antigens From Intercell AG, Accelerates Research On Antibody Drug Development


4/13/2006 2:31:25 PM

Tokyo, Apr 11, 2006 (JCN) - Kirin Brewery and Intercell AG have entered into a strategic alliance whereby Kirin will receive the worldwide exclusive rights to develop, manufacture and sell pneumococcal antigens identified by Intercell, a Vienna-based company specializing in vaccines development.

Read at JCN Newswire

comments powered by Disqus
   
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES